서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 23 of 23

Issue DateTitle / Author(s) / CitationFileAltmetrics
2001-12
BIO-COMPATIBILITY OF THE POLYIMIDE-BASED MICROELECTRODE ARRAYS FOR ARTIFICIAL RETINAL IMPLANT

Kim, Hyokyum; Kim, Euitae; Lee, Hoseung; Seo, Jong-Mo; Chung, Hum; Yu, Youngsuk; Kim, Sung June

The Korean Society for Brain and Neural Sciences Experimental NEUROBIOLOGY Vol. 10 No. 2 suppl. Dec. 2001, P-149(p151)

view file
2006-09
Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary study
link
2006-09
Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary study
link
2008-09
Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole
link
2010-04
ALTERED FUNCTIONAL CONNECTIVITY IN SUBJECTS WITH ULTRA-HIGH RISK FOR PSYCHOSIS USING RESTING STATE FMRI
DOI
2010-10
Altered resting-state connectivity in subjects at ultra-high risk for psychosis: an fMRI study
view fileDOI
2010-10
Altered resting-state connectivity in subjects at ultra-high risk for psychosis: an fMRI study
view fileDOI
2011-08
Social cognition and neurocognition as predictors of conversion to psychosis in individuals at ultra-high risk
DOI
2011-09
What is the optimal dose of escitalopram for the treatment of obsessive-compulsive disorder? A naturalistic open-label study

Shim, Geumsook; Park, Hye Youn; Jang, Joon Hwan; Kim, Euitae; Park, Hye Yoon; Hwang, Jae Yeon; Kim, Sung Nyun; Jang, Go-Eun; Kwon, Jun Soo

International Clinical Psychopharmacology, Vol.26 No.5, pp.284-290

DOI
2017-04
Regional Differences in Serotonin Transporter Occupancy by Escitalopram: An [C-11] DASB PK-PD Study
DOI
2017-11
Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors
DOI
2018-01
Higher serotonin transporter availability in early‐onset obsessive–compulsive disorder patients undergoing escitalopram treatment: A [11C]DASB PET study
view fileDOI
2018-04
The relationship between dopamine receptor blockade and cognitive performance in schizophrenia: A [11C]-raclopride PET study with aripiprazole
view fileDOI
2019-11
Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: An [18F]DOPA PET and fMRI study
DOI
2020-02
Clinical and psychosocial factors associated with depression in patients with psychosis according to stage of illness
DOI
2020-02
Defining Treatment Response, Remission, Relapse, and Recovery in First-Episode Psychosis: A Survey among Korean Experts
DOI
2020-04
Study Protocol for a Prospective Longitudinal Cohort Study to Identify Proteomic Predictors of Pluripotent Risk for Mental Illness: The Seoul Pluripotent Risk for Mental Illness Study
DOI
2020-09
Dissociation in Pharmacokinetic Attenuation Between Central Dopamine D2 Receptor Occupancy and Peripheral Blood Concentration of Antipsychotics: A Systematic Review
DOI
2020-12
Effects of antipsychotics on rumination in patients with first-episode psychosis
DOI
2021-04
The relationship between grey matter volume and striatal dopamine function in psychosis: a multimodal F18-DOPA PET and voxel-based morphometry study
DOI
2022-01
Comparison of clinical features and 1-year outcomes between patients with psychotic disorder not otherwise specified and those with schizophrenia
DOI
2022-07
The Relationship Between Frontostriatal Connectivity and Striatal Dopamine Function in Schizophrenia: An 18F-DOPA PET and Diffusion Tensor Imaging Study in Treatment Responsive and Resistant Patients
DOI
2022-08
DNA Methylation Profiles of the DRD2 and NR3C1 Genes in Patients with Recent-Onset Psychosis
DOI
1